Cart
sales@molnova.com
Dihydrolycorine
CAS No. 6271-21-2
Dihydrolycorine ( —— )
Catalog No. M18922 CAS No. 6271-21-2
Dihydrolycorine-HCL(DL) shows hypotensive effects, it can block alpha 1-adrenoceptors.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 71 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 194 | In Stock |
|
| 50MG | 296 | In Stock |
|
| 100MG | 525 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydrolycorine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydrolycorine-HCL(DL) shows hypotensive effects, it can block alpha 1-adrenoceptors.
-
DescriptionDihydrolycorine-HCL(DL) shows hypotensive effects, it can block alpha 1-adrenoceptors. Dihydrolycorine is an inhibitors of protein synthesis in eukarytic cells, it halts protein synthesis in eukaryotic cells by inhibiting the peptide bone formation step. Dihydrolycorine and nimodipine protects against anoxia damage of brain in rat.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6271-21-2
-
Formula Weight289.33
-
Molecular FormulaC16H19NO4
-
Purity98%
-
Solubility——
-
SMILESC1CN2CC3=CC4=C(C=C3C5C2C1CC(C5O)O)OCO4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Carubicin
Carubicin (Carminomycin) is an apoptosis inducer that targets the Golgi complex.
-
ACBI1
ACBI1 is a potent PROTAC degrader of BAF ATPase subunits SMARCA2 and SMARCA4, also degrades the polybromo-associated BAF (PBAF) complex member PBRM1, with DC50s of 6 nM, 11 nM and 32 nM for SMARCA2, SMARCA4 and PBRM1 in MV-4-11 cells, respectively.
-
Naphthazarin
Naphthazarin is effective by various cellular mechanisms including oxidative stress, activation of mitochondrial apoptosis-inducing factor (AIF), depolymerization of microtubules, interference with lysosomal function and p53-dependent p21 activation.
